Literature DB >> 27666285

Inappropriate Clostridium difficile Testing and Consequent Overtreatment and Inaccurate Publicly Reported Metrics.

Sean G Kelly1, Michael Yarrington2, Teresa R Zembower1, Sarah H Sutton1, Christina Silkaitis3, Michael Postelnick4, Anessa Mikolajczak5, Maureen K Bolon1.   

Abstract

BACKGROUND The nationally reported metric for Clostridium difficile infection (CDI) relies solely on laboratory testing, which can result in overreporting due to asymptomatic C. difficile colonization. OBJECTIVE To review the clinical scenarios of cases of healthcare facility-onset CDI (HO-CDI) and to determine the appropriateness of C. difficile testing on the basis of presence of symptomatic diarrhea in order to identify areas for improvement. DESIGN Retrospective cohort study. SETTING Northwestern Memorial Hospital, a large, tertiary academic hospital in Chicago, Illinois. PATIENTS The cohort included all patients with a positive C. difficile test result who were reported to the National Healthcare Safety Network as HO-CDI during a 1-year study period. METHODS We reviewed the clinical scenario of each HO-CDI case. On the basis of documentation and predefined criteria, appropriateness of C. difficile testing was determined; cases were deemed appropriate, inappropriate, or indeterminate. Statistical analysis was performed to compare demographic and clinical parameters among the categories of testing appropriateness. RESULTS Our facility reported 168 HO-CDI cases to NHSN during the study period. Of 168 cases, 33 (19.6%) were judged to be appropriate tests, 25 (14.8%) were considered inappropriate, and 110 (65.5%) were indeterminate. Elimination of inappropriate testing would have improved our facility's standardized infection ratio from 0.962 to 0.819. CONCLUSION Approximately 15% of HO-CDI cases were judged to be tested inappropriately. Testing only patients with clinically significant diarrhea would more accurately estimate CDI incidence, reduce unnecessary antibiotic use, and improve facilities' performance of reportable CDI metrics. Improved documentation could facilitate targeted interventions. Infect Control Hosp Epidemiol 2016;1395-1400.

Entities:  

Mesh:

Year:  2016        PMID: 27666285     DOI: 10.1017/ice.2016.210

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  12 in total

1.  Use of Computerized Clinical Decision Support for Diagnostic Stewardship in Clostridioides difficile testing: an Academic Hospital Quasi-Experimental Study.

Authors:  Anne E Friedland; Sara Brown; Danielle R Glick; Martha C Lusby; Daniel Lemkin; Surbhi Leekha
Journal:  J Gen Intern Med       Date:  2019-01       Impact factor: 5.128

2.  Preventable Patient Harm: a Multidisciplinary, Bundled Approach to Reducing Clostridium difficile Infections While Using a Glutamate Dehydrogenase/Toxin Immunochromatographic Assay/Nucleic Acid Amplification Test Diagnostic Algorithm.

Authors:  Katherine Schultz; Emily Sickbert-Bennett; Ashley Marx; David J Weber; Lauren M DiBiase; Stacy Campbell-Bright; Lauren E Bode; Mike Baker; Tom Belhorn; Mark Buchanan; Sherie Goldbach; Jacci Harden; Emily Hoke; Beth Huenniger; Jonathan J Juliano; Michael Langston; Heather Ritchie; William A Rutala; Jason Smith; Shelley Summerlin-Long; Lisa Teal; Peter Gilligan
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

3.  The Role of Diagnostic Stewardship in Clostridioides difficile Testing: Challenges and Opportunities.

Authors:  Frances J Boly; Kimberly A Reske; Jennie H Kwon
Journal:  Curr Infect Dis Rep       Date:  2020-02-17       Impact factor: 3.725

4.  Characterizing Risk Factors for Clostridioides difficile Infection among Hospitalized Patients with Community-Acquired Pneumonia.

Authors:  Caroline C Jozefczyk; W Justin Moore; Paul R Yarnold; Nathaniel J Rhodes; Karolina Harkabuz; Robert Maxwell; Sarah H Sutton; Christina Silkaitis; Chao Qi; Richard G Wunderink; Teresa R Zembower
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

Review 5.  Clostridium difficile: Diagnosis and the Consequence of Over Diagnosis.

Authors:  Helen S Lee; Kamryn Plechot; Shruti Gohil; Jennifer Le
Journal:  Infect Dis Ther       Date:  2021-03-26

6.  Prevalence of and factors associated with inappropriate Clostridioides difficile testing in a teaching hospital in Korea.

Authors:  Hee Bum Jo; Sin Young Ham; Jongtak Jung; Song Mi Moon; Nak-Hyun Kim; Kyoung-Ho Song; Jeong Su Park; Kyoung Un Park; Eu Suk Kim; Hong Bin Kim
Journal:  Antimicrob Resist Infect Control       Date:  2022-05-13       Impact factor: 4.887

7.  Identification of Clostridium difficile Asymptomatic Carriers in a Tertiary Care Hospital.

Authors:  André Luiz de Oliveira Silva; Alexandre R Marra; Marinês Dalla Valle Martino; Ana Carolina Cintra Nunes Mafra; Michael B Edmond; Oscar Fernando Pavao Dos Santos
Journal:  Biomed Res Int       Date:  2017-10-02       Impact factor: 3.411

8.  Longitudinal investigation of carriage rates and genotypes of toxigenic Clostridium difficile in hepatic cirrhosis patients.

Authors:  Yunbo Chen; Hongqin Gu; Tao Lv; Dong Yan; Qiaomai Xu; Silan Gu; Ping Shen; Jiazheng Quan; Yunhui Fang; Lifeng Chen; Guangyong Ye; Lanjuan Li
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

Review 9.  Direct Measurement of Performance: A New Era in Antimicrobial Stewardship.

Authors:  Majdi N Al-Hasan; Hana Rac Winders; P Brandon Bookstaver; Julie Ann Justo
Journal:  Antibiotics (Basel)       Date:  2019-08-24

10.  Diagnostic Stewardship for Healthcare-Associated Infections: Opportunities and Challenges to Safely Reduce Test Use.

Authors:  Gregory R Madden; Robert A Weinstein; Costi D Sifri
Journal:  Infect Control Hosp Epidemiol       Date:  2018-01-14       Impact factor: 3.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.